Our study analyzed the correlation of FDX1 and tumor immune status including tumor infiltrating immune cells, immunoscore, TMB and MSI etc. Clinical studies have confirmed the important role of CD274 (PD-L1) expression level in immune checkpoint inhibitor (ICI) therapy in lung cancer including LUAD. This evidence concerns the gene CD274 and lung cancer.